- Release Date: 27/06/14 12:10
- Summary: Sun Biomedical Completes First Phase of Oraline Testing
- Price Sensitive: Yes
- Download Document 41.29KB
- Forums
- ASX - By Stock
- SBN
- Ann: Sun Biomedical Completes First Phase of Oraline Testing
Ann: Sun Biomedical Completes First Phase of Oraline Testing
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online